🔎 Trials Near Me

Beranda › Kanker Hati › Washington › Seattle

Uji klinis Kanker Hati di Seattle, WA

5 studi untuk Kanker Hati mencari peserta di lokasi sekitar Seattle (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.

Teks studi resmi (Bahasa Inggris)

Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →

Symbiotic-GI-13: A Study to Learn About Study Medicine Called PF-08634404 as a Single Treatment and Combination Treatment in Adult Participants With a Liver Cancer Called Hepatocellular Carcinoma, That is Too Advanced to be Removed by Surgery and May Have Spread to Other Parts of the Body.

Menerima pesertaFase 1/2
  • Virginia Mason Medical Center, Seattle
  • Fred Hutchinson Cancer Center, Seattle
  • University of Washington Medical Center- Montlake, Seattle
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 28 Sep 2026 · NCT07227012

GPC3-Targeted T-Cell Therapy (ECT204) in Adults With Advanced HCC

Menerima pesertaFase 1/2
  • Fred Hutchinson Cancer Center, University of Washington, Seattle
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 10 Sep 2026 · NCT04864054

Preventing Liver Cancer Mortality Through Imaging With Ultrasound vs. MRI

Menerima peserta
  • VA Puget Sound Health Care System Seattle Division, Seattle, WA, Seattle
Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 17 Jun 2026 · NCT05486572

Immunotherapy for Solid Tumor Malignancies in Pediatrics Using Interleukin-15 and -21 Armored Glypican-3-specific Chimeric Antigen Receptor T Cells

Menerima pesertaFase 1
  • Seattle Children's Hospital, Seattle
Usia 1 hingga 26 · Semua jenis kelamin · Diperbarui 17 Feb 2026 · NCT07148050

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Menerima pesertaStudi observasional
  • Massive Bio SYNERGY-AI site, Seattle
Semua usia · Semua jenis kelamin · Diperbarui 28 Okt 2025 · NCT03452774

Uji klinis Kanker Hati di kota lain

Studi lain di Seattle

Dari ClinicalTrials.gov, data diambil 5 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.